On May 26, an analyst from Morgan Stanley reiterated his cautious stance on United States Steel Corp. (NYSE:X) with an ...

The bank is unveiling 14 new format branches in tony ZIP codes in New York, California, Florida and Massachusetts, among ...

Morgan Stanley analyst Michael Ulz downgraded Rocket Pharmaceuticals (RCKT) to Equal Weight from Overweight with a price target of $7, down from ...

The robotaxi ride-hailing service is coming to the “safest” parts of Austin in June with plenty of human oversight.

Morgan Stanley closed 9.03% short of its 52-week high of $142.03, which the company reached on February 7th.

We initiate MS with a Buy rating and $162 PT, as market underestimates durability and scale of earnings rebound underway.

Morgan Stanley maintained its price target of $150 while reaffirming its Overweight rating on PDD Holdings Inc. (NASDAQ:PDD) ...

Bicara Therapeutics Inc. (NASDAQ:BCAX) is a clinical-stage biopharmaceutical company that develops innovative bifunctional ...

Morgan Stanley named Nvidia its "top pick" among semiconductor stocks Tuesday, a day before the chipmaker's expected earnings ...

Nvidia investors will want to hear how new U.S. government rules are impacting the still-meteoric growth of the AI chip ...

While many analysts still count Nvidia as a top tech pick, they're also cautious on overhangs related to China restrictions ...

Morgan Stanley cut National Storage Affiliates (NSA) to Underweight from Equalweight as the bank's analysis of job openings ...